On this page you will find all of ACB’s publications. To the right are the search categories that will help you navigate around the ACB’s extensive work.
Across the world, the use of bilateral trade instruments to prise open markets for genetically modified (GM) crops is escalating. To expand business overseas, the biotech industry needs stronger intellectual property rules and weaker biosafety standards. Bilateral trade deals are an effective way to do this.